Surgical Innovations Group (SUN)

Sector:

Health Care

Index:

FTSE AIM All-Share

 NULL
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: NULL
  • 52 Week Low: 1.00p
  • Currency: UK Pounds
  • Shares Issued: 932.82m
  • Volume: 0
  • RiskGrade: 341
  • Beta: 0.00

Surgical Innovations expecting bumper second half

By Josh White

Date: Tuesday 26 Jun 2018

LONDON (ShareCast) - (Sharecast News) - Designer, manufacturer and distributor of innovative medical technology, Surgical Innovations Group, said on Tuesday that total group revenues for the six months ending 30 June were expected to exceed £5m.
The AIM-traded firm told shareholders at its annual general meeting that profitability was also expected to be "slightly ahead" of the corresponding period last year, with it also anticipating "much stronger results" in the second half of the year.

Executive chairman Nigel Rogers said export sales of SI branded products were gaining increasing traction in many overseas markets, as a result of product range extensions, additional sales resources and business development initiatives.

"We anticipate further opportunities to improve our market share across several key geographical markets to be delivered in the coming months," he told the meeting.

"Market conditions in the UK during the first half of the year have been challenging as a result of reduced activity levels of elective surgery in the NHS, and the supply chain disruption in respect of the Cellis range of biological matrices."

Rogers said there were positive signs that NHS hospitals were continuing to return to normalised activity levels, with recent government policy announcements regarding a longer-term funding settlement for the NHS described as "encouraging".

"Distribution sales in the UK market will also benefit from additional product lines taken on during the first half of the year, and the renewal of a number of key contracts.

"Revenues from OEM customers have been steady, and are expected to increase in the second half of the year, following the redesign of certain key products and additional revenues from precision engineering products."

Rogers said the company's management had used the period of subdued demand to bear down further on working capital, delivering "significant reductions" in inventory levels and strong cash flow.

"The group is expected to have little or no net debt at 30 June."

Surgical Innovations said its interim results for the first half of the year would be released in September.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SUN Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 0.000p
% Change 0.00 %
52 Week High NULL
52 Week Low 1.00p
Volume 0
Shares Issued 932.82m
Beta 0.00
RiskGrade 341

SUN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.36% above the market average50.36% above the market average50.36% above the market average50.36% above the market average50.36% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
14.25% below the market average14.25% below the market average14.25% below the market average14.25% below the market average14.25% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Income Not Available
Growth
12.13% below the market average12.13% below the market average12.13% below the market average12.13% below the market average12.13% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SUN Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

SUN Key Personnel

CEO David Marsh
Chair Jonathan Glenn

Top of Page